152 related articles for article (PubMed ID: 21354804)
1. Evaluation of BPA uptake in clear cell sarcoma (CCS) in vitro and development of an in vivo model of CCS for BNCT studies.
Fujimoto T; Andoh T; Sudo T; Fujita I; Imabori M; Moritake H; Sugimoto T; Sakuma Y; Takeuchi T; Sonobe H; Epstein AL; Akisue T; Kirihata M; Kurosaka M; Fukumori Y; Ichikawa H
Appl Radiat Isot; 2011 Dec; 69(12):1713-6. PubMed ID: 21354804
[TBL] [Abstract][Full Text] [Related]
2. Boron neutron capture therapy for clear cell sarcoma (CCS): biodistribution study of p-borono-L-phenylalanine in CCS-bearing animal models.
Andoh T; Fujimoto T; Sudo T; Fujita I; Imabori M; Moritake H; Sugimoto T; Sakuma Y; Takeuchi T; Kawabata S; Kirihata M; Akisue T; Yayama K; Kurosaka M; Miyatake S; Fukumori Y; Ichikawa H
Appl Radiat Isot; 2011 Dec; 69(12):1721-4. PubMed ID: 21367607
[TBL] [Abstract][Full Text] [Related]
3. Boron neutron capture therapy as new treatment for clear cell sarcoma: trial on different animal model.
Andoh T; Fujimoto T; Sudo T; Suzuki M; Sakurai Y; Sakuma T; Moritake H; Sugimoto T; Takeuchi T; Sonobe H; Epstein AL; Fukumori Y; Ono K; Ichikawa H
Appl Radiat Isot; 2014 Jun; 88():59-63. PubMed ID: 24389062
[TBL] [Abstract][Full Text] [Related]
4. Boron neutron capture therapy (BNCT) as a new approach for clear cell sarcoma (CCS) treatment: Trial using a lung metastasis model of CCS.
Andoh T; Fujimoto T; Suzuki M; Sudo T; Sakurai Y; Tanaka H; Fujita I; Fukase N; Moritake H; Sugimoto T; Sakuma T; Sasai H; Kawamoto T; Kirihata M; Fukumori Y; Akisue T; Ono K; Ichikawa H
Appl Radiat Isot; 2015 Dec; 106():195-201. PubMed ID: 26337135
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy.
Dagrosa MA; Viaggi M; Rebagliati RJ; Batistoni D; Kahl SB; Juvenal GJ; Pisarev MA
Mol Pharm; 2005; 2(2):151-6. PubMed ID: 15804189
[TBL] [Abstract][Full Text] [Related]
6. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo evaluation of o-carboranylalanine as a potential boron delivery agent for neutron capture therapy.
Yong JH; Barth RF; Wyzlic IM; Soloway AH; Rotaru JH
Anticancer Res; 1995; 15(5B):2033-8. PubMed ID: 8572598
[TBL] [Abstract][Full Text] [Related]
8. L-DOPA preloading increases the uptake of borophenylalanine in C6 glioma rat model: a new strategy to improve BNCT efficacy.
Capuani S; Gili T; Bozzali M; Russo S; Porcari P; Cametti C; D'Amore E; Colasanti M; Venturini G; Maraviglia B; Lazzarino G; Pastore FS
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):562-7. PubMed ID: 18793958
[TBL] [Abstract][Full Text] [Related]
9. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of 4-borono-2-18F-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model.
Wang HE; Liao AH; Deng WP; Chang PF; Chen JC; Chen FD; Liu RS; Lee JS; Hwang JJ
J Nucl Med; 2004 Feb; 45(2):302-8. PubMed ID: 14960653
[TBL] [Abstract][Full Text] [Related]
11. Selective uptake of p-boronophenylalanine by osteosarcoma cells for boron neutron capture therapy.
Ferrari C; Zonta C; Cansolino L; Clerici AM; Gaspari A; Altieri S; Bortolussi S; Stella S; Bruschi P; Dionigi P; Zonta A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S341-4. PubMed ID: 19394838
[TBL] [Abstract][Full Text] [Related]
12. Hydroxylforms of p-boronophenylalanine as potential boron carriers on boron neutron capture therapy for malignant brain tumors.
Takagaki M; Ono K; Oda Y; Kikuchi H; Nemoto H; Iwamoto S; Cai J; Yamamoto Y
Cancer Res; 1996 May; 56(9):2017-20. PubMed ID: 8616843
[TBL] [Abstract][Full Text] [Related]
13. Selective uptake of para-boronophenylalanine increases in amelanotic melanoma cells transfected by the tyrosinase gene.
Hiratsuka J; Kondoh H; Tsuboi T; Yoshino K; Imajo Y; Mishima Y
Melanoma Res; 2000 Jun; 10(3):297-302. PubMed ID: 10890385
[TBL] [Abstract][Full Text] [Related]
14. Experimental Studies of Boronophenylalanine ((10)BPA) Biodistribution for the Individual Application of Boron Neutron Capture Therapy (BNCT) for Malignant Melanoma Treatment.
Carpano M; Perona M; Rodriguez C; Nievas S; Olivera M; Santa Cruz GA; Brandizzi D; Cabrini R; Pisarev M; Juvenal GJ; Dagrosa MA
Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):344-52. PubMed ID: 26232853
[TBL] [Abstract][Full Text] [Related]
15. Boron neutron capture therapy (BNCT) inhibits tumor development from precancerous tissue: an experimental study that supports a potential new application of BNCT.
Monti Hughes A; Heber EM; Pozzi E; Nigg DW; Calzetta O; Blaumann H; Longhino J; Nievas SI; Aromando RF; Itoiz ME; Trivillin VA; Schwint AE
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S313-7. PubMed ID: 19376711
[TBL] [Abstract][Full Text] [Related]
16. The hamster cheek pouch as a model of oral cancer for boron neutron capture therapy studies: selective delivery of boron by boronophenylalanine.
Kreimann EL; Itoiz ME; Dagrosa A; Garavaglia R; Farías S; Batistoni D; Schwint AE
Cancer Res; 2001 Dec; 61(24):8775-81. PubMed ID: 11751398
[TBL] [Abstract][Full Text] [Related]
17. Improvement of the tumor-suppressive effect of boron neutron capture therapy for amelanotic melanoma by intratumoral injection of the tyrosinase gene.
Morita N; Hiratsuka J; Kondoh H; Uno M; Asano T; Niki Y; Sakurai Y; Ono K; Harada T; Imajo Y
Cancer Res; 2006 Apr; 66(7):3747-53. PubMed ID: 16585201
[TBL] [Abstract][Full Text] [Related]
18. Boron neutron capture therapy (BNCT) selectively destroys human clear cell sarcoma in mouse model.
Fujimoto T; Andoh T; Sudo T; Fujita I; Moritake H; Sugimoto T; Sakuma T; Akisue T; Kawabata S; Kirihata M; Suzuki M; Sakurai Y; Ono K; Fukumori Y; Kurosaka M; Ichikawa H
Appl Radiat Isot; 2013 Mar; 73():96-100. PubMed ID: 23306161
[TBL] [Abstract][Full Text] [Related]
19. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy.
Smith DR; Chandra S; Barth RF; Yang W; Joel DD; Coderre JA
Cancer Res; 2001 Nov; 61(22):8179-87. PubMed ID: 11719448
[TBL] [Abstract][Full Text] [Related]
20. Biodistribution of the boron carriers boronophenylalanine (BPA) and/or decahydrodecaborate (GB-10) for Boron Neutron Capture Therapy (BNCT) in an experimental model of lung metastases.
Trivillin VA; Garabalino MA; Colombo LL; González SJ; Farías RO; Monti Hughes A; Pozzi EC; Bortolussi S; Altieri S; Itoiz ME; Aromando RF; Nigg DW; Schwint AE
Appl Radiat Isot; 2014 Jun; 88():94-8. PubMed ID: 24360862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
